Back

Incidence of cardiovascular events following vericiguat initiation in patients with heart failure with or without a recent worsening heart failure event: a hospital-based real-world cohort study

29 August 2025 (07:00 - 18:00)
Organised by: Logo
Congress Presentation Part of: Comprehensive heart failure care Pharmacotherapy ESC Professional Premium Access ESC Congress 2025 European Society of Cardiology

About the speaker

Photo
Assistant Professor Shun Kohsaka

Keio University School of Medicine, Tokyo (Japan)

6 More presentations in this session

Presentation thumbnail
The role of a structured patient education programme in the complex care of patients with heart failure
Doctor F. Banfi-Bacsardi (Budapest, HU)
Abstract Slides Video
Presentation thumbnail
Prognostic value of combined assessment of heart rate rise and recovery during cardiopulmonary exercise test on clinical outcomes in patients with chronic heart failure
Doctor Y. Shimono (Sapporo, JP)
Abstract Slides Video
Presentation thumbnail
Unveiling gaps in heart failure management in Germany: a retrospective analysis of national data and healthcare utilisation patterns
Professor J. Muller-Ehmsen (Bremen, DE)
Abstract Slides Video
Presentation thumbnail
Exploring Kidney functions as a key barrier to effective diuresis in Congestion Refractory Heart Failure: Insights from the DEA-HF Clinical Trial
Doctor I. Volis (Haifa, IL)
Abstract Slides Video
Presentation thumbnail
Impact of pulmonary hypertension on clinical outcomes among patients undergoing transcatheter mitral valve edge to edge repair
Doctor F. Nunez Guzman (Hackensack, US)
Abstract Slides Video

Access the full session

Session thumbnail
Comprehensive heart failure care

The Event

Event poster

ESC Congress 2025

29 August - 1 September 2025
You may be interested in
thumbnail
Congress Presentation
Characteristics, patterns of co-medications and dose titration in heart failure patients using vericiguat in real-world clinical settings in Japan.
thumbnail
Congress Presentation
Vericiguat in a real-world heart failure population: a single-centre experience
thumbnail
Congress Presentation
In-hospital initiation of Vericiguat and short-term cardiovascular function improvement in heart failure patients with worsened renal function

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources